Galux

Galux has developed a proprietary AI drug discovery platform capable of designing proteins and antibodies from scratch. The company has built a cutting-edge AI platform based on deep learning, enhanced by strategically applied physicochemical insights, enabling highly accurate predictions and the generation of novel antibodies.